VivoSeq
Other

Vancomycin

0

Pipeline Programs↗

8

Active Trials↗

5

Companies Involved↗

Vancomycin is an early-stage landscape with 0 programs across 5 companies. The most active players are Melinta Therapeutics, Inc., Merck & Co., LigaChem Biosciences, Inc..

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

65/100

Attrition Rate

21/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

Melinta Therapeutics, Inc.

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalL

LigaChem Biosciences, Inc.

0 programs

PreclinicalN

NeuTec Pharma

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

39

clinical trials

Completed15 · 38%
Unknown status8 · 21%
Terminated8 · 21%
Not yet recruiting4 · 10%
Recruiting3 · 8%
Active, not recruiting1 · 3%

Clinical Trials

Trial Activity

39 trials

Exploring Vancomycin Disposition in Neonates
Recruiting·UUniversitaire Ziekenhuizen KU Leuven·Phase 4·NCT02096536·120 enrolled
Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane
Recruiting·MMahidol University·N/A·NCT06543940·8 enrolled
Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model
Recruiting·—·Phase 4·NCT06161870·112 enrolled
IO Vancomycin in TSA
Active, not recruiting·TThe Methodist Hospital Research Institute·Phase 4·NCT05831774·33 enrolled
IO Vancomycin Spine
Not yet recruiting·TThe Methodist Hospital Research Institute·Phase 2/3·NCT06748144·30 enrolled
Haemoglobin And Vancomycin Pharmacokinetics in the Cerebrospinal Fluid Following Subarachnoid Haemorrhage
Not yet recruiting·UUniversity Hospital Southampton NHS Foundation Trust·N/A·NCT06373640·14 enrolled
First Time Right of Vancomycin
Not yet recruiting·EErasmus Medical Center·N/A·NCT05964114·134 enrolled
IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA
Not yet recruiting·TThe Methodist Hospital Research Institute·N/A·NCT07283068·40 enrolled
Pharmacokinetics of Vancomycin in Adults Receiving ECMO
Completed·NNational Taiwan University Hospital·Phase 4·NCT00281281·24 enrolled
The Influencing Factors of Vancomycin Trough Level and the Rate Achieving the Target Trough Level
Completed·SSoutheast University, China·N/A·NCT03806543·165 enrolled
Vancomycin vs. Vancomycin Plus Gentamycin in Treatment of MRSA Infection
Completed·MMichael E. DeBakey VA Medical Center·Phase 4·NCT00304811·160 enrolled
The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin
Completed·HHospital Universitario Evangelico de Curitiba·Phase 4·NCT01626560·20 enrolled
Model-informed Precision Dosing of Vancomycin in Adults
Completed·UUniversity Hospital, Ghent·Phase 4·NCT05535075·155 enrolled
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
Completed·MMelinta Therapeutics, Inc.·Phase 3·NCT01252732·1,019 enrolled
RCT of Continuous Versus Intermittent Infusion of Vancomycin in Neonates
Completed·MMurdoch Childrens Research Institute·N/A·NCT02210169·111 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)